Table 3 Distribution of primary and secondary study endpoints as well as preservation solutions to the different eras, 580 patients from the Kiel liver transplant program

9 (1.6%)

96 (16.6%)

152 (26.2%)

323 (55.7%)

n.a.

0 (0%)

8 (8.3%)

68 (44.7%)

281 (87.0%)

<0.001¹

9 (100.0%)

88 (91.7%)

84 (55.3%)

42 (13%)

<0.001¹

3 (33.3%)

22 (22.9%)

35 (23.0%)

32 (9.9%)

<0.001¹

8 (88.9%)

59 (61.5%)

75 (49.7%)

85 (26.5%)

<0.001¹

6 (66.7%)

68 (70.8%)

106 (69.7%)

262 (81.1%)

0.021¹

1 (11.1%)

33 (34.4%)

47 (30.9%)

18 (19.4%)

0.099¹